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Background: This study was designed to assess the prevalence of metabolic syndrome and its correlated factors in
an urban population in Ahvaz.
Methods: This descriptive analytical study performed with random cluster sampling method in 6 health centers in
Ahvaz. In each selected center, 55 households were randomly selected. A questionnaire included: age, sex, marital
status, ethnicity, education level, family history of diabetes (DM), Hypertension (HTN) and obesity, smoking and
parity and previous history of gestational diabetes Mellitus in women were filled for each person.
Blood pressure, weight, height, body mass index (BMI), abdominal and waist circumference were measured in each
participant. Fasting blood glucose (FBS), serum total cholesterol, triglyceride and high density lipoprotein (HDL)
level were measured in fasting blood sample.
Results: The mean age of all participants was 42.27 ± 14 years (44.2 ± 14.26 years in men and 40.5 ± 13.5 in
women). From total 912 participant, 434(47.2%) were men and 478(52.8%) women. Prevalence of metabolic
syndrome based on ATPIII criteria (update2005) was 22.8% (15.9% in men and 29.1% in women) that showed
significant difference (P = 0.0001). Prevalence of each component of MS in studied population was: 29.4% for
abdominal obesity, 40.7% for high TG level, 40.2% for low HDL, 15.4% for hypertension and 37.8% for abnormal FBS.
Among these factor, age of patients, BMI, sex had significant differences between persons with or without Ms
(P = 0.0001). Ethnicity (Arab or Persian), cigarette smoking and family history of diabetes mellitus, hypertension and
obesity, marital statues, education level, parity and previous history of GDM in women showed no significant
differences between persons with MS and without MS.
Conclusion: Metabolic syndrome has high prevalence in our population and its prevalence increases with
increasing age and BMI. Women are at higher risk for metabolic syndrome than men.
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Blood glucoseIntroduction
Metabolic syndrome (MS) or X syndrome refers to sim-
ultaneous occurrence of cardiovascular risk factors or
type 2 diabetes such as abdominal obesity, high blood
pressure and abnormal carbohydrate and lipid metabol-
ism (hypertriglyceridemia, elevated blood glucose) and
decrease in high density lipoprotein (HDL) level [1].
Although there are various definitions for metabolic* Correspondence: sml1381@yahoo.com
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distribution, and reproduction in any mediumsyndrome, but the most practical method in clinical
diagnosis is using Adult treatment Panel III (ATPIII).
According to this definition the person must have at
least three factors of cardiovascular risk factors at the
same time. Studies have shown that there is a coinci-
dence of metabolic factors in different individuals, and
coexistence of these factors is more harmful than one of
them [2]. As a matter of fact metabolic syndrome is like
a bridge between diabetes and cardiovascular disease [1].
About 50% of patients with type 2 diabetes are suffe-
ring from metabolic syndrome and these people have
more chances for stroke, retinopathy, neuropathy andtral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Table 1 Prevalence of metabolic syndrome according to










20-29 203 13(6.4) 3.59-10.94 1
30-39 198 29(14.6) 10.14-20.47 2.51
40-49 226 61(27) 21.43-33.37 5.40
50-59 176 59(33.5) 26.68-41.05 7.37
60-69 80 34(42.5) 31.68-54.05 10.8
≤ 70 29 12(41.4) 24.8-60.89 1.32
Total 912 208(22.8)
Men
20-29 87 5(5.7) 2.11-13.44 1
30-39 78 11(14.1) 7.58-24.25 2.69
40-49 112 20(17.9) 11.54-26.52 3.57
50-59 94 16(17) 13.2-26.45 3.36
60-69 44 11(25) 13.7-40.65 5.47
≤ 70 19 6(31.6) 13.57-56.52 7.57
Total 434 69(15.9)
Women
20-29 116 8(6.9) 3.24-13.56 1
30-39 120 18(15) 9.37-22.94 2.38
40-49 114 41(36) 27.38-45.48 7.58
50-59 82 43(52.4) 41.14-63.43 14.88
60-69 36 23(63.9) 46.22-78.67 23.88
≤ 70 10 6(60) 27.37-86.31 20.25
Total 478 139(29.1)
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half people with Acute Coronary syndrome have three
or more Components of metabolic syndrome [3]. High
prevalence of metabolic syndrome (95%) has been
reported in patients with Peripheral Arterial Disease [4].
Prevalence of metabolic syndrome is increasing in diffe-
rent region like Asia [5] and developing countries [6].
Prevalence of metabolic syndrome has been reported bet-
ween 12.8% to 41.1% in different part of the world [7]. In
DECODE study that was conducted in 9 European coun-
tries, MS was detected in 32% of men and 28.5% of women
[8]. Prevalence of MS was reported in recent studies in
Estonia 25.9% [9], Norway 25.9% [10], turkey 28/8% [11]
and luxamburg 24/7% [12].
Studies in different provinces in Iran showed that the
prevalence of metabolic syndrome was between 21.9%
to 31.1% [1,2,13,14]. Many factors including: age, race,
weight, menopause in women, smoking, low income
economies, high carbohydrate intake, no alcohol con-
sumption, low physical activity [15], consumption of soft
drink [16], antipsychotic drugs [17] poor cardiovascular
fitness [18] and Genetic factors may play a role in meta-
bolic syndrome. However, early identification of patients
and treatment with appropriate medical and educational
programs can be an effective step in control and reduce
the incidence of metabolic syndrome and also cardiovas-
cular disease and diabetes [1]. This study was designed
to assess the prevalence of MS and its risk factors in an
urban population in Ahvaz (South West of Iran).
Materials and methods
This descriptive analytical study performed with random
cluster sampling method in 6 health center in Ahvaz. In
each selected center, 55 households were randomly
selected. After obtaining informed consent by volun-
teers, they were invited to participate in this study.
A questionnaire included: age, sex, marital status, ethni-
city, education level, family history of diabetes (DM),
Hypertension (HTN) and obesity, smoking and parity and
previous history of gestational diabetes Mellitus in women
were filled for each person. Blood pressure, weight, height,
body mass index (BMI) [Weigh(kg)/Height(m)2], abdo-
minal and waist circumference were measured in each
participant. Blood pressure was measured by a standard
sphygmomanometer after 15 minutes rest in a sitting pos-
ition. The cuff was placed on the right arm at the heart
level and then quickly pushes the device until 30 mm Hg
above radial pulse disappearance. Blood pressure was
measured twice at least 30 minutes interval between two
measurement and mean of these two measurements, was
taken as blood pressure. Anthropometric measurements
were taken after removing shoes and wearing a light dress.
Weight and height were measured according to the stan-
dard program. Waist circumference was measured at themidpoint between the lowest rib and the upper lateral
border of the right iliac crest and hip circumference at the
point of maximum hip diameter.
After 12 h of fasting, blood samples were taken in the
morning. Samples was centrifuged, serum stored in the
refrigerator and was sent to Diabetes Research Center
laboratory.
Triglyceride (TG), Fasting Blood Sugar (FBS), Cholesterol
and high density lipoprotein (HDL) were measured using
an enzymatic colorimetric method with Pars Azmoon kit.
(With Biotechnical instruments model BT-3000 Germany).
For diagnosis of metabolic syndrome at least three of
the following five components were considered necessary
(according to ATP III criteria update 2005) [19,20].
1. Abdominal obesity (Waist circumference ≥ 102 cm in
men and ≥ 88 cm in women).
2. TG ≥ 150 mg/dl or history of drug consumption for
hypertriglyceridemia.
3. HDL ≤ 40 mg/dl in men and ≤50 mg/dl in women or
history of drug consumption.
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or history of anti hypertensive drug consumption.
5. FBS ≥100 mg/dl, history of diabetes mellitus history
or using anti diabetic drugs.
Sample size was calculated as 912 and EPI2000 descrip-
tive statistics was used to provide figures and tables.
Chi-square test, logistic regression and trend test was used
for correlation assessment SPSS software 19 and EPI2000
descriptive statistics was used to provide figures and
tables. P = 0 < 0.05 was considered as significant.Results
From total 912 participant, 434 (47.2%) were men and 478
(52.8%) women. The mean age of all participants was
42.27 ± 14 years (44.2 ± 14.26 years in men and 40.5 ± 13.5
in women). Prevalence of metabolic syndrome based on
ATPIII criteria (update2005) was 22.8% (15.9% in men
and 29.1% in women) that showed significant difference
(P = 0.0001).
Trend test showed increased prevalence of metabolic
syndrome with increasing age in total sample and both
sexes. (P = 0.0001) (Table 1).
Figure 1 shows the prevalence of MS in different age
group in both sexes.
The highest prevalence of metabolic syndrome was
42.5% that was seen in age group 60–69 years (31.6% in
men in with ≥70 years, 63.9% in women with 60–69 years).
Prevalence of each component of MS in studied popula-
















Figure 1 Prevalence of Metabolic syndrome in different sex and agelevel, 40.2% for low HDL, 15.4% for hypertension and
37.8% for abnormal FBS (15.3% DM and 22.6% impaired
fasting glucose (IFG).
Abdominal obesity showed highest prevalence in age
group 50–59 years (39.1%). High TG was more prevalent in
50–59 years group (52.2%) and Low HDL in 30–39 years
(47.3%). The highest prevalence of high blood pressure and
abnormal FBS were seen in age group ≥ 70 years (50% and
62.1% respectively) Prevalence of each component of MS in
both sexes in each age group was shown in Table 2.
In total subjects, 22% were normal (no any component
of MS) 29.9% had one component, 26.1% two, 13.8%
three, 6.9% four and 1.4% have five component of meta-
bolic syndrome (Table 3).
The prevalence of abdominal obesity was 15% in men
and 42.4% in women that showed significant difference
(P = 0.0001). The prevalence of hypertriglyceridemia was
higher in men (47.8%) than women (34.2%) with signi-
ficant difference (P = 0.0001). Low HDL was detected in
50.7% of women and 28.5% of men with significant diffe-
rence (P = 0.0001). Rate of high blood pressure (BP ≥
130/85) in men was 13.7% and in women 16.9% with no
significant difference (P = 0.17). Prevalence of high FBS
was 40.8% in men and 35.1% in women that showed sig-
nificant difference (P = 0.041). Factors that can affect the
incidence of MS are seen in Table 4.
Among these factor, age of patients, BMI, sex, had sig-
nificant differences between persons with or without MS
(P = 0.0001). Ethnicity (Arab or Persian), cigarette smok-
ing and family history of diabetes, hypertension and
obesity, marital status, level of education, and parity>=7060- 6950- 599
age
group.















20-29 13 22.9 42 0.5 17.1
30-39 30.3 35.5 47.3 6.5 22
40-49 32.9 48.2 41.1 12.2 45.7
50-59 39.1 52.2 32.8 31.5 55.3
60-69 35.8 51.3 33.3 35.8 60
≤ 70 33.3 41.4 36.7 50 62.1
Total 29.4 40.7 40.2 15.4 37.8
Men
20-29 10.2 32.2 30.7 0 21.8
30-39 18.8 45.6 38.8 7.5 27.8
40-49 14.2 53.6 23 9.7 47.3
50-49 16.8 56.4 25.3 23.2 52.6
60-69 11.4 54.5 22.7 25 56.8
≤ 70 21.1 36.8 36.8 52.6 47.4
Total 15 47.8 28.5 13.7 40.8
Women
20-29 15.1 16.1 50.4 0.8 13.6
30-39 38 28.9 52.9 5.8 18.2
40-49 50.8 43.1 58.5 14.7 44.1
50-49 64.3 47.6 41.2 41 58.3
60-69 64.9 47.2 45.9 48.6 63.9
≤ 70 54.5 50 36.4 45.5 90
Total 42.4 34.2 50.7 16.9 35.1
Table 4 Logistic regression model
B S.E P value OR Confidence Interval(CI)
Sex 0.73 0.24 0.00 2.08 1.30-3.33
Marriage status -0.32 0.46 0.47 0.72 0.29-1.78
Ethnic -0.36 0.24 0.13 0.69 0.43-1.11
Smoking 0.52 0.38 0.17 1.69 0.79-3.61
Family history
Overweight 0.44 0.23 0.05 1.56 0.99-2.45
Diabetes -0.08 0.23 0.71 0.91 0.57-1.45
HTN 0.14 0.22 0.52 1.15 0.74-1.80
BMI
BMI ≤ 19 1
19.1-24.99 0.25 1.11 0.81 1.29 0.14-11.39
25-29.99 1.00 1.10 0.36 2.73 0.31-23.80
≥30 2.34 1.10 0.03 10.42 1.18-91.40
Age
20-29 1
30-39 0.38 0.44 0.37 1.47 0.62-3.49
40-49 1.57 0.44 0.00 4.82 2.02-11.48
50-59 1.90 0.45 0.00 6.69 2.75-16.30
60-69 2.58 0.52 0.00 13.19 4.74-36.70
≥70 2.25 0.70 0.01 9.57 2.39-38.20
Education level
Non educated 1
Primary 0.02 0.33 0.93 1.03 0.53-1.98
High school -0.54 0.33 0.10 0.58 0.30-1.12
University -0.42 0.42 0.31 0.65 0.28-1.50
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cant differences between persons with MS and without
MS (P > 0.05).Discussion
The metabolic syndrome is an important risk factors for
diabetes type 2 and cardiovascular diseases, thus the clinicalTable 3 Number of metabolic syndrome component in
studied population
No. of component No. %
No any component 200 22
1 component 272 29.9
2 component 238 26.1
3 component 126 13.8
4 component 63 6.9
5 component 13 1.4
Total 912 100implication of diagnosis of MS is identification of patients
who needs aggressive life style modification [21-23].
The results of this study showed that the prevalence of
metabolic syndrome is high in studied population and it
increases with increment of age and BMI significantly.
The prevalence of MS was 22.8% (15.9% in men 29.4%
in women) with significant difference. Smoking, ethni-
city, level of education, family history of diabetes, hyper-
tension and obesity, marital status, and parity and
history of GDM in women had no effects on prevalence
of MS.
The prevalence of MS in this study is similar to studies
in Zanjan 23% [24] and Zahedan 21% [25] but lower than
some other studies in Iran. MS was detected in 32% of
population in Yazd [2] and about 30% in Tehran [13,14].
One reason for these differences may be heterogeneity of
studied population. In this study, only about 31% of the
population was in age group higher than 50 years, but in
Yazd [2] study more than 50% of population was in this
high risk age group. Given the increasing prevalence of
metabolic syndrome with increasing age, this can be one
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factors, race, nutrition and physical activity can also have
an impact on the prevalence of MS. Differences in preva-
lence of metabolic syndrome in communities are because
of differences in prevalence of each component of MS.
For example, diabetes prevalence in this study was 15.3%
but it was 25.7% in Tehran [13] study.
Prevalence of low HDL in our study was 40.2%, but in
Tehran study it was 63% [13], in Yazd [2] 35% in men
and 64% in women and in Zanjan [24] 93% in women
and 63% in men.
Genetic factors are important in the incidence of low
HDL. Existence of specific genes in addition to nutrition
and physical activity and smoking can have effect on the
prevalence of low HDL [26-30]. The prevalence of MS has
been reported in other parts of the world with different
diagnostic criteria. In a study in USA 34.5% of people had
MS based on ATPIII 2002 criteria [31].
In DECODE study that was conducted in 9 European
countries, MS was detected in 32% of men and 28.5% of
women [8]. High prevalence of MS was reported in re-
cent studies in Estonia 25.9% [9], Norway 25.9% [10],
Turkey 28/8% [11] and luxamburg 24/7% [12].
In a recent study in Korea [32] MS was seen in 6.4%
of adolescences and 22.3% of adults.
Many factors including: age, race, weight, menopause
in women, smoking, low income economies, high carbo-
hydrate intake, no alcohol consumption, low physical ac-
tivity [15], consumption of soft drink [16], antipsychotic
drugs [17], poor cardiovascular fitness [18] and Genetic
factors may play a role in metabolic syndrome.
A parental history of metabolic syndrome increases the
risk, and genetic factors may account for as much as 50%
of the variable in level of metabolic syndrome traits in off-
spring [33-36]. In most studies (2, 8.12) increasing age was
the key factor affecting the prevalence of metabolic syn-
drome and it also showed in our study. Increasing in BMI
was correlate with increasing prevalence of MS in this
study. This is in agreement with other studies [37]. There
is controversy about the relation between sex and MS in
different studies. In this study, prevalence of metabolic syn-
drome was significantly higher in women than men. This is
in agreement with other studies (2, 8, 14, 37). But in some
studies, the prevalence of MS in men is more than women
[38]. That’s may be become of reduction of physical activity
in Iranian women than may cause higher rate of abdominal
obesity and low HDL. Genetic, cultural, physical activity
and nutritional differences can be the cause of controver-
sies. This association was seen in some other studies
[39,40]. In this study, smoking, ethnicity (Arabs and
Persians) and marital status and education does not affect
the rate of metabolic syndrome. Smoking more than 20
cigarettes per day has been associated with increased risk
of metabolic syndrome in some studies [41,42].Strengths of this study are that it is a population based
study in an urban population of Iran, extensive information
of confounders and a relatively large sample size. One limi-
tation was that, this study was cross sectional that does not
allow us to draw any causal interference. Therefore in the
future large prospective studies should be used to confirm
the association between above mentioned factors and
metabolic syndrome.
Conclusions
Metabolic syndrome has high prevalence in our popula-
tion and its prevalence increases with increasing age and
BMI. Women are at higher risk for MS than men.
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